FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma (DBCOND0120406)
Identifiers
- Synonyms
- Not Available
Associated Data
- Indicated Drugs and Targets
- Not Available
- Clinical Trials
Identifier Title Drug(s) Purpose Phase Status NCT05538897 Testing the Addition of the AKT Inhibitor, Ipatasertib, to Treatment With the Hormonal Agent Megestrol Acetate for Recurrent or Metastatic Endometrial Cancers treatment 1 / 2 recruiting NCT02397083 Levonorgestrel-Releasing Intrauterine System With or Without Everolimus in Treating Patients With Atypical Hyperplasia or Stage IA Grade 1 Endometrial Cancer treatment 2 active_not_recruiting NCT06213571 Remote Home-Based Exercise Program for Strength Training in Endometrial Cancer Survivors in Rural Areas No drug interventions supportive_care Not Available recruiting NCT04092270 A Study Combining the Peposertib (M3814) Pill With Standard Chemotherapy in Patients With Ovarian Cancer With an Expansion in High Grade Serous Ovarian Cancer and Low Grade Serous Ovarian Cancer treatment 1 recruiting NCT03018249 Medroxyprogesterone Acetate With or Without Entinostat Before Surgery in Treating Patients With Endometrioid Endometrial Cancer basic_science 0 completed NCT04604613 Prediction of Recurrence Among Low Risk Endometrial Cancer Patients No drug interventions Not Available Not Available recruiting NCT03300557 Exemestane in Treating Patients With Complex Atypical Hyperplasia of the Endometrium/Endometrial Intraepithelial Neoplasia or Low Grade Endometrial Cancer prevention 2 active_not_recruiting